Valuation : Ambee Pharmaceuticals Plc

Market Cap 1.82B 14.79M 12.72M 11.98M 10.92M 20.42M 1.41B 20.5M 142M 54.87M 717M 55.52M 54.31M 2.27B P/E 2024
189x
P/E 2025 369x
Enterprise Value 2.32B 18.91M 16.27M 15.32M 13.96M 26.12M 1.8B 26.22M 182M 70.18M 917M 71M 69.46M 2.9B EV / Sales 2024
10.4x
EV / Sales 2025 10.7x
Free-Float
22.75%
Yield 2024
0.13%
Yield 2025 0.12%
1 day-0.05%
1 week+0.53%
Current month-0.38%
1 month-6.49%
3 months-3.34%
6 months-2.68%
Current year+6.29%
1 week 750
Extreme 750
799.9
1 month 742.2
Extreme 742.2
808
Current year 689
Extreme 689
847
1 year 681
Extreme 681
847
3 years 650
Extreme 650
1,302.3
5 years 375.3
Extreme 375.3
1,302.3
10 years 353
Extreme 352.999999
1,302.3
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%+0.53%-9.67%+14.41% 14.69M
-1.11%-3.46%+17.16%+64.97% 47.73B
-2.10%-6.62%+37.45%+113.68% 40.21B
-1.58%-2.32%+8.86%+79.48% 12.05B
-1.51%-3.52%-12.15%+9.52% 11.79B
+0.38%+0.19%+19.18%+137.27% 9.16B
-0.13%-5.62%+34.94%-17.57% 7.39B
-1.60%-1.02%+15.06%+213.45% 7.37B
0.00%-1.72%+20.96%+33.90% 7.34B
+1.32%+0.10%-43.62%+22.77% 5.13B
Average -0.64%-1.66%+8.82%+67.19% 14.82B
Weighted average by Cap. -1.19%-2.67%+18.65%+79.68%

Financials

2024 2025
Net sales 219M 1.79M 1.54M 1.45M 1.32M 2.47M 170M 2.48M 17.15M 6.63M 86.57M 6.71M 6.56M 274M 231M 1.88M 1.62M 1.52M 1.39M 2.59M 179M 2.6M 18.03M 6.97M 91.01M 7.05M 6.9M 288M
Net income 9.68M 78.86K 67.86K 63.89K 58.22K 109K 7.5M 109K 757K 293K 3.82M 296K 290K 12.11M 5.31M 43.24K 37.2K 35.03K 31.92K 59.72K 4.11M 59.96K 415K 160K 2.1M 162K 159K 6.64M
Net Debt 445M 3.62M 3.12M 2.93M 2.67M 5M 345M 5.02M 34.77M 13.44M 176M 13.6M 13.3M 556M 506M 4.12M 3.55M 3.34M 3.04M 5.7M 392M 5.72M 39.59M 15.3M 200M 15.48M 15.15M 633M
Logo Ambee Pharmaceuticals Plc
Ambee Pharmaceuticals Plc is a Bangladesh-based company. The business of the Company is to manufacture, buy, sell, export, or deal in all kinds of drugs, medicines, pharmaceuticals, chemicals, medical or any other preparations. It refines, manipulates or treats all such substances used in the pharmaceutical industry. The Company offers tablets, capsules, liquids, gel in tubes, and injectables. Its products include ANTAC, LAP, OM-20, OM-40, STOMACID, AMBEECLOX, AMBEEXIN, FLUXIN, MYCEF, MYCEF-DS, TRICEF, A-ROX, MYCIN, MYZID, HIFLOX, HIFLOX-XR, LEXLO, DOXILLIN, TETRAM, TACTIN, NALIDEX, AFLUZOLE, AFUVIN, KLION, AMETROL-VT, TRIBEN-DS, TRIBEN, SURAL, MESPA, NO-SPA, AMINOPHYLLINE, CODEX, DEXTROMETHORPHAN, NILKOF, ACES PLUS, AMBEECAL, AMBEECAL D, ACT, ACT PLUS, AROLAK, AROLAK-10, AROLAK30, HITFLAM, HITFLAM-SR, NAPROXIN, CINON, FUNGAKIL, AMASON, PREDNISOLONE, NOSTIS, ALUCTIN, NOCTIN, SEDUXEN, and PERO-L. The Company has approximately nine sales centers in all over Bangladesh.
Employees
474
Date Price Change Volume
26-09-09 BDT 752.50 -0.05% 878
26-09-08 BDT 752.90 -0.57% 1,138
26-09-07 BDT 757.20 -0.26% 952
26-09-06 BDT 759.20 +1.77% 882
26-09-03 BDT 746.00 -0.33% 1,521
  1. Stock Market
  2. Stocks
  3. AMBEEPHA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!